InvestorsHub Logo
Followers 3
Posts 114
Boards Moderated 0
Alias Born 08/14/2017

Re: None

Saturday, 12/09/2017 7:41:07 PM

Saturday, December 09, 2017 7:41:07 PM

Post# of 8022
I love hearing folks nit pick. Maci wasn't even FDA approved a year ago. Vericel had an amazing year of GROWTH. Biopsies are up, they are hiring nation wide, and they managed to find ICT to get the product line a strong footprint in Asia. I expect 2018 to be an even Stronger year. The is no competition in the market. Any "would be" contenders are many rounds of dilution and trials away . Epicel has been the dark horse for 2017 and should continue into 2018 as it clearly is getting into the hands of hospitals and burn centers. This has only just begun. plus if you think Ixcell will rot on a shelf, I have advice for you.
Cover Now!
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent VCEL News